| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 2942020 | JACC: Cardiovascular Interventions | 2009 | 9 Pages | 
Abstract
												This large, international multicenter registry provides important information regarding the long-term safety and efficacy of the Endeavor ZES across standard and extended-use patients in the real-world setting. Rates of MACE and measures of safety including cardiac death, myocardial infarction, and stent thrombosis were low and consistent with pooled results of clinical trials. (E-Five Registry: A World-Wide Registry With The Endeavor Zotarolimus Eluting Coronary Stent [eFive Registry]; NCT00623441)
											Keywords
												multicenter registryPESzotarolimus-eluting stent(s)CECTLRBMSTVFPCIMACECK-MBtarget lesion revascularizationSESMyocardial infarctionDESdrug-eluting stent(s)paclitaxel-eluting stent(s)bare-metal stent(s)sirolimus-eluting stent(s)drug-eluting stentStent thrombosisrestenosismajor adverse cardiac eventsZEStarget vessel failureCoronary artery lesionTarget vessel revascularizationArcpercutaneous coronary interventionTVRclinical events committeeAcademic Research Consortiumcreatine kinase-myocardial band
												Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Cardiology and Cardiovascular Medicine
												
											Authors
												Chaim MD, Ian T. MBBS, PhD, Laura MD, MSc, Minglei PhD, Martin T. MB, ChB, E-Five Investigators E-Five Investigators, 
											